European Commission - Daily News
Brussels, 22 July 2016
The European Commission has approved under the EU Merger Regulation the proposed acquisition of Meda AB of Sweden by Mylan N.V. of the Netherlands, subject to conditions. Both companies operate in the pharmaceutical sector.
The decision is conditional upon the divestment of a number of Mylan's or Meda's businesses in Austria, Belgium, Estonia, France, Luxembourg, Ireland, Italy, Norway, Portugal, Spain and the UK. The Commission had concerns that the transaction, as initially notified, would have reduced competition on the markets for several pharmaceutical products. The commitments offered by Mylan address these concerns. The Commission's decision to approve the transaction is conditional upon full compliance with the commitments. A full press release is available in EN, FR, DE, SV and NL.
(For more information: Ricardo Cardoso – Tel.: +32 229 80100; Giulia Komel – Tel.: +32 229 61175)
Source: Europa.eu (Copyright European Commission)